Gujarat Terce Laboratories Limited share price
BSE: GUJTERC
Key numbers
- Market cap
- ₹ 30.6 Cr
- Current price
- ₹ 39.29
- 52-week high / low
- ₹ 60 / 29
- Stock P/E
- 14.3
- Book value
- ₹ 12.5
- Dividend yield
- 0.00%
- ROCE
- 34.6%
- ROE
- 27.1%
- Debt to equity
- 0.13
- Sales growth (3 yrs)
- 0.5%
- Profit growth (3 yrs)
- -
- 1-year return
- -3.7%
About Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, and Codimol brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is based in Ahmedabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 11 | 13 | 12 | 11 | 9 |
| Operating profit | -0 | 2 | 1 | 1 | -0 |
| Net profit | -0 | 1 | 1 | 0 | -0 |
| EPS (₹) | -0.06 | 1.89 | 0.95 | 0.13 | -0.23 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.